Despite declining revenues and industry growth, Honz Pharmac...

Despite declining revenues and industry growth, Honz Pharmaceutical's P/S ratio matches the industry, hinting at a potential share price drop unless medium-term circumstances improve. Shareholders may face a tough period ahead.